Risk factors affecting visual outcomes following dropped nucleus after cataract surgery
Background/ Aims To describe the visual outcomes in eyes with dropped nucleus during phacoemulsification surgery. Setting Singapore National Eye Centre (SNEC). Design Retrospective chart review of prospectively reported cases of dropped nucleus. Methods The clinical charts of all cases of dropped nu...
Gespeichert in:
Veröffentlicht in: | Eye (London) 2024-02, Vol.38 (2), p.253-258 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 258 |
---|---|
container_issue | 2 |
container_start_page | 253 |
container_title | Eye (London) |
container_volume | 38 |
creator | Hu, Jeremy Youwei Ti, Seng-Ei Chee, Soon-Phaik |
description | Background/ Aims
To describe the visual outcomes in eyes with dropped nucleus during phacoemulsification surgery.
Setting
Singapore National Eye Centre (SNEC).
Design
Retrospective chart review of prospectively reported cases of dropped nucleus.
Methods
The clinical charts of all cases of dropped nucleus (Jan 2001 to Dec 2016) were retrospectively reviewed for patient demographics, surgeon type, stage of surgery, timing of pars plana vitrectomy (PPV), and complications. Visual success was defined as best corrected visual acuity (BCVA) ≥ 20/40 at last review. Final risk factors affecting visual success were identified using multivariate logistic regression analysis.
Results
Incidence of dropped nucleus following cataract surgery was 0.17% (
n
= 292). Duration of follow-up was 25.5 months (mean), 18.5 months (median). There was a statistically significant difference in dropped nucleus rate between Residents (0.3%) and Faculty (0.14%) (x
2
= 38.2,
P
70 years, absence of intraocular lens (IOL) implant, and presence of major complications.
Conclusion
Overall incidence of dropped nucleus in SNEC was 0.17%, with BCVA of 20/40 or better in 85.2% cases. Visual prognosis was influenced by patient’s age, presence of IOL implant or additional major complications. |
doi_str_mv | 10.1038/s41433-023-02668-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10810779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2846931755</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-bef50da859386b9eff8784138d67527969c486c272d4ae63f366dc1143c69d1a3</originalsourceid><addsrcrecordid>eNp9kUtLJDEUhYMo2j7-gIuhwM1sSvN-rERkfIAgiKK7kE4lbWl1pSepKP57U7Y6jgsXIYvz3ZN7cgDYRXAfQSIPEkWUkBri8XAua7UCJogKXjPK6CqYQMVgjTG-2wCbKT1AWEQB18EGEYxiJMgE3F616bHyxg4hpsp47-zQ9rPqqU3ZdFXIgw1zlyofui48j0oTw2LhmqrPtnN5nBlcrKwZTCwuVcpx5uLLNljzpktu5_3eAjcnf66Pz-qLy9Pz46OL2hKJh3rqPIONkUwRyafKeS-FpIjIhguGheLKUsktFrihxnHiCeeNRSW35apBhmyBw6XvIk_nrrGuH6Lp9CK2cxNfdDCt_l_p23s9C08aQYmgEKo4_H53iOFvdmnQ8zZZ13WmdyEnjSXliiDBWEH3vqEPIce-5NNYIUkhkmSk8JKyMaQUnf_cBkE9FqeXxelSnH4rTo9b_Pqa43Pko6kCkCWQitSXL_739g-2r7E8pS8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918401835</pqid></control><display><type>article</type><title>Risk factors affecting visual outcomes following dropped nucleus after cataract surgery</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>PubMed Central</source><creator>Hu, Jeremy Youwei ; Ti, Seng-Ei ; Chee, Soon-Phaik</creator><creatorcontrib>Hu, Jeremy Youwei ; Ti, Seng-Ei ; Chee, Soon-Phaik</creatorcontrib><description>Background/ Aims
To describe the visual outcomes in eyes with dropped nucleus during phacoemulsification surgery.
Setting
Singapore National Eye Centre (SNEC).
Design
Retrospective chart review of prospectively reported cases of dropped nucleus.
Methods
The clinical charts of all cases of dropped nucleus (Jan 2001 to Dec 2016) were retrospectively reviewed for patient demographics, surgeon type, stage of surgery, timing of pars plana vitrectomy (PPV), and complications. Visual success was defined as best corrected visual acuity (BCVA) ≥ 20/40 at last review. Final risk factors affecting visual success were identified using multivariate logistic regression analysis.
Results
Incidence of dropped nucleus following cataract surgery was 0.17% (
n
= 292). Duration of follow-up was 25.5 months (mean), 18.5 months (median). There was a statistically significant difference in dropped nucleus rate between Residents (0.3%) and Faculty (0.14%) (x
2
= 38.2,
P
< 0.001), but ensuing major complications rates were similar. PPV was performed in 251 eyes (87.2%). At final examination, 202 cases (85.2%) achieved BCVA 20/40 or better, after excluding patients with co-existing ocular pathology. Timing of vitrectomy (delayed vs same-day) did not influence the final visual success (x
2
= 0.969,
p
= 0.51). Risk factors for poor visual outcomes included age >70 years, absence of intraocular lens (IOL) implant, and presence of major complications.
Conclusion
Overall incidence of dropped nucleus in SNEC was 0.17%, with BCVA of 20/40 or better in 85.2% cases. Visual prognosis was influenced by patient’s age, presence of IOL implant or additional major complications.</description><identifier>ISSN: 0950-222X</identifier><identifier>ISSN: 1476-5454</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/s41433-023-02668-9</identifier><identifier>PMID: 37542173</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/499 ; 692/699/3161/3168 ; Acuity ; Aged ; Cataract - etiology ; Cataract Extraction - adverse effects ; Cataracts ; Eye ; Eye surgery ; Humans ; Intraocular lenses ; Laboratory Medicine ; Lens Implantation, Intraocular - adverse effects ; Medicine ; Medicine & Public Health ; Ophthalmology ; Patients ; Phacoemulsification - adverse effects ; Pharmaceutical Sciences/Technology ; Postoperative Complications - epidemiology ; Postoperative Complications - etiology ; Retrospective Studies ; Risk Factors ; Statistical analysis ; Success ; Surgery ; Surgical Oncology ; Vitrectomy - adverse effects</subject><ispartof>Eye (London), 2024-02, Vol.38 (2), p.253-258</ispartof><rights>The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c382t-bef50da859386b9eff8784138d67527969c486c272d4ae63f366dc1143c69d1a3</cites><orcidid>0000-0002-3803-1019</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810779/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810779/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37542173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Jeremy Youwei</creatorcontrib><creatorcontrib>Ti, Seng-Ei</creatorcontrib><creatorcontrib>Chee, Soon-Phaik</creatorcontrib><title>Risk factors affecting visual outcomes following dropped nucleus after cataract surgery</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><description>Background/ Aims
To describe the visual outcomes in eyes with dropped nucleus during phacoemulsification surgery.
Setting
Singapore National Eye Centre (SNEC).
Design
Retrospective chart review of prospectively reported cases of dropped nucleus.
Methods
The clinical charts of all cases of dropped nucleus (Jan 2001 to Dec 2016) were retrospectively reviewed for patient demographics, surgeon type, stage of surgery, timing of pars plana vitrectomy (PPV), and complications. Visual success was defined as best corrected visual acuity (BCVA) ≥ 20/40 at last review. Final risk factors affecting visual success were identified using multivariate logistic regression analysis.
Results
Incidence of dropped nucleus following cataract surgery was 0.17% (
n
= 292). Duration of follow-up was 25.5 months (mean), 18.5 months (median). There was a statistically significant difference in dropped nucleus rate between Residents (0.3%) and Faculty (0.14%) (x
2
= 38.2,
P
< 0.001), but ensuing major complications rates were similar. PPV was performed in 251 eyes (87.2%). At final examination, 202 cases (85.2%) achieved BCVA 20/40 or better, after excluding patients with co-existing ocular pathology. Timing of vitrectomy (delayed vs same-day) did not influence the final visual success (x
2
= 0.969,
p
= 0.51). Risk factors for poor visual outcomes included age >70 years, absence of intraocular lens (IOL) implant, and presence of major complications.
Conclusion
Overall incidence of dropped nucleus in SNEC was 0.17%, with BCVA of 20/40 or better in 85.2% cases. Visual prognosis was influenced by patient’s age, presence of IOL implant or additional major complications.</description><subject>692/499</subject><subject>692/699/3161/3168</subject><subject>Acuity</subject><subject>Aged</subject><subject>Cataract - etiology</subject><subject>Cataract Extraction - adverse effects</subject><subject>Cataracts</subject><subject>Eye</subject><subject>Eye surgery</subject><subject>Humans</subject><subject>Intraocular lenses</subject><subject>Laboratory Medicine</subject><subject>Lens Implantation, Intraocular - adverse effects</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Ophthalmology</subject><subject>Patients</subject><subject>Phacoemulsification - adverse effects</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - etiology</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Statistical analysis</subject><subject>Success</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Vitrectomy - adverse effects</subject><issn>0950-222X</issn><issn>1476-5454</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtLJDEUhYMo2j7-gIuhwM1sSvN-rERkfIAgiKK7kE4lbWl1pSepKP57U7Y6jgsXIYvz3ZN7cgDYRXAfQSIPEkWUkBri8XAua7UCJogKXjPK6CqYQMVgjTG-2wCbKT1AWEQB18EGEYxiJMgE3F616bHyxg4hpsp47-zQ9rPqqU3ZdFXIgw1zlyofui48j0oTw2LhmqrPtnN5nBlcrKwZTCwuVcpx5uLLNljzpktu5_3eAjcnf66Pz-qLy9Pz46OL2hKJh3rqPIONkUwRyafKeS-FpIjIhguGheLKUsktFrihxnHiCeeNRSW35apBhmyBw6XvIk_nrrGuH6Lp9CK2cxNfdDCt_l_p23s9C08aQYmgEKo4_H53iOFvdmnQ8zZZ13WmdyEnjSXliiDBWEH3vqEPIce-5NNYIUkhkmSk8JKyMaQUnf_cBkE9FqeXxelSnH4rTo9b_Pqa43Pko6kCkCWQitSXL_739g-2r7E8pS8</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Hu, Jeremy Youwei</creator><creator>Ti, Seng-Ei</creator><creator>Chee, Soon-Phaik</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3803-1019</orcidid></search><sort><creationdate>20240201</creationdate><title>Risk factors affecting visual outcomes following dropped nucleus after cataract surgery</title><author>Hu, Jeremy Youwei ; Ti, Seng-Ei ; Chee, Soon-Phaik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-bef50da859386b9eff8784138d67527969c486c272d4ae63f366dc1143c69d1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/499</topic><topic>692/699/3161/3168</topic><topic>Acuity</topic><topic>Aged</topic><topic>Cataract - etiology</topic><topic>Cataract Extraction - adverse effects</topic><topic>Cataracts</topic><topic>Eye</topic><topic>Eye surgery</topic><topic>Humans</topic><topic>Intraocular lenses</topic><topic>Laboratory Medicine</topic><topic>Lens Implantation, Intraocular - adverse effects</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Ophthalmology</topic><topic>Patients</topic><topic>Phacoemulsification - adverse effects</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - etiology</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Statistical analysis</topic><topic>Success</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Vitrectomy - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Jeremy Youwei</creatorcontrib><creatorcontrib>Ti, Seng-Ei</creatorcontrib><creatorcontrib>Chee, Soon-Phaik</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Jeremy Youwei</au><au>Ti, Seng-Ei</au><au>Chee, Soon-Phaik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors affecting visual outcomes following dropped nucleus after cataract surgery</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>38</volume><issue>2</issue><spage>253</spage><epage>258</epage><pages>253-258</pages><issn>0950-222X</issn><issn>1476-5454</issn><eissn>1476-5454</eissn><abstract>Background/ Aims
To describe the visual outcomes in eyes with dropped nucleus during phacoemulsification surgery.
Setting
Singapore National Eye Centre (SNEC).
Design
Retrospective chart review of prospectively reported cases of dropped nucleus.
Methods
The clinical charts of all cases of dropped nucleus (Jan 2001 to Dec 2016) were retrospectively reviewed for patient demographics, surgeon type, stage of surgery, timing of pars plana vitrectomy (PPV), and complications. Visual success was defined as best corrected visual acuity (BCVA) ≥ 20/40 at last review. Final risk factors affecting visual success were identified using multivariate logistic regression analysis.
Results
Incidence of dropped nucleus following cataract surgery was 0.17% (
n
= 292). Duration of follow-up was 25.5 months (mean), 18.5 months (median). There was a statistically significant difference in dropped nucleus rate between Residents (0.3%) and Faculty (0.14%) (x
2
= 38.2,
P
< 0.001), but ensuing major complications rates were similar. PPV was performed in 251 eyes (87.2%). At final examination, 202 cases (85.2%) achieved BCVA 20/40 or better, after excluding patients with co-existing ocular pathology. Timing of vitrectomy (delayed vs same-day) did not influence the final visual success (x
2
= 0.969,
p
= 0.51). Risk factors for poor visual outcomes included age >70 years, absence of intraocular lens (IOL) implant, and presence of major complications.
Conclusion
Overall incidence of dropped nucleus in SNEC was 0.17%, with BCVA of 20/40 or better in 85.2% cases. Visual prognosis was influenced by patient’s age, presence of IOL implant or additional major complications.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>37542173</pmid><doi>10.1038/s41433-023-02668-9</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3803-1019</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0950-222X |
ispartof | Eye (London), 2024-02, Vol.38 (2), p.253-258 |
issn | 0950-222X 1476-5454 1476-5454 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10810779 |
source | MEDLINE; SpringerLink Journals; PubMed Central |
subjects | 692/499 692/699/3161/3168 Acuity Aged Cataract - etiology Cataract Extraction - adverse effects Cataracts Eye Eye surgery Humans Intraocular lenses Laboratory Medicine Lens Implantation, Intraocular - adverse effects Medicine Medicine & Public Health Ophthalmology Patients Phacoemulsification - adverse effects Pharmaceutical Sciences/Technology Postoperative Complications - epidemiology Postoperative Complications - etiology Retrospective Studies Risk Factors Statistical analysis Success Surgery Surgical Oncology Vitrectomy - adverse effects |
title | Risk factors affecting visual outcomes following dropped nucleus after cataract surgery |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20affecting%20visual%20outcomes%20following%20dropped%20nucleus%20after%20cataract%20surgery&rft.jtitle=Eye%20(London)&rft.au=Hu,%20Jeremy%20Youwei&rft.date=2024-02-01&rft.volume=38&rft.issue=2&rft.spage=253&rft.epage=258&rft.pages=253-258&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/s41433-023-02668-9&rft_dat=%3Cproquest_pubme%3E2846931755%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918401835&rft_id=info:pmid/37542173&rfr_iscdi=true |